Washington Trust Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-200
Closed -$8K 612
2018
Q3
$8K Hold
200
﹤0.01% 554
2018
Q2
$7K Sell
200
-699
-78% -$21.1K ﹤0.01% 553
2018
Q1
$25K Hold
899
﹤0.01% 490
2017
Q4
$22K Buy
899
+699
+350% +$19.3K ﹤0.01% 536
2017
Q3
$6K Buy
+200
New +$5.52K ﹤0.01% 618
2017
Q1
Sell
-105
Closed -$2K 719
2016
Q4
$2K Sell
105
-46
-30% -$1K ﹤0.01% 662
2016
Q3
$4K Sell
151
-37
-20% -$883 ﹤0.01% 623
2016
Q2
$4K Buy
+188
New +$4.07K ﹤0.01% 654

Other funds holding BSX

Washington Trust Bank's BSX Position: Q4 2018 in Review

Washington Trust Bank sold out of Boston Scientific (BSX) in Q4 2018, closing a stake of 200 shares — an estimated $8K sold.

Washington Trust Bank first reported a position in BSX in Q2 2016 and held it in 8 quarters. The position peaked at $25K in Q1 2018. 731 funds tracked by Wall St. Rank hold BSX as of Q4 2018.

  • Washington Trust Bank reported no remaining Boston Scientific position as of Q4 2018 after selling out during the quarter.
  • Washington Trust Bank sold 200 Boston Scientific shares in Q4 2018, an estimated $8K.
  • Washington Trust Bank first reported a position in Boston Scientific in Q2 2016 and held it in 8 quarters.
  • Washington Trust Bank's Boston Scientific position peaked at $25K in Q1 2018.
  • 731 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2018.

Based on Washington Trust Bank's 13F filing for Q4 2018, filed 13 Feb 2019.